324 related articles for article (PubMed ID: 7479976)
1. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination.
Scherer DC; Brockman JA; Chen Z; Maniatis T; Ballard DW
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11259-63. PubMed ID: 7479976
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase.
Yaron A; Gonen H; Alkalay I; Hatzubai A; Jung S; Beyth S; Mercurio F; Manning AM; Ciechanover A; Ben-Neriah Y
EMBO J; 1997 Nov; 16(21):6486-94. PubMed ID: 9351830
[TBL] [Abstract][Full Text] [Related]
3. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.
Chen Z; Hagler J; Palombella VJ; Melandri F; Scherer D; Ballard D; Maniatis T
Genes Dev; 1995 Jul; 9(13):1586-97. PubMed ID: 7628694
[TBL] [Abstract][Full Text] [Related]
4. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
Alkalay I; Yaron A; Hatzubai A; Orian A; Ciechanover A; Ben-Neriah Y
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10599-603. PubMed ID: 7479848
[TBL] [Abstract][Full Text] [Related]
5. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo.
Rodriguez MS; Wright J; Thompson J; Thomas D; Baleux F; Virelizier JL; Hay RT; Arenzana-Seisdedos F
Oncogene; 1996 Jun; 12(11):2425-35. PubMed ID: 8649784
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells.
Marienfeld R; Neumann M; Chuvpilo S; Escher C; Kneitz B; Avots A; Schimpl A; Serfling E
Eur J Immunol; 1997 Jul; 27(7):1601-9. PubMed ID: 9247567
[TBL] [Abstract][Full Text] [Related]
7. Degradation of proto-oncoprotein c-Rel by the ubiquitin-proteasome pathway.
Chen E; Hrdlickova R; Nehyba J; Longo DL; Bose HR; Li CC
J Biol Chem; 1998 Dec; 273(52):35201-7. PubMed ID: 9857058
[TBL] [Abstract][Full Text] [Related]
8. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B.
Traenckner EB; Wilk S; Baeuerle PA
EMBO J; 1994 Nov; 13(22):5433-41. PubMed ID: 7957109
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.
Palombella VJ; Rando OJ; Goldberg AL; Maniatis T
Cell; 1994 Sep; 78(5):773-85. PubMed ID: 8087845
[TBL] [Abstract][Full Text] [Related]
10. Activation of the protein kinase A increases the DNA-binding and transcriptional activity of c-Rel in T cells.
Lahdenpohja N; Henttinen T; Hurme M
Scand J Immunol; 1996 Jun; 43(6):640-5. PubMed ID: 8658053
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of IkappaB-alpha and IkappaB-beta proteolysis by calpain inhibitor I blocks nitric oxide synthesis.
Milligan SA; Owens MW; Grisham MB
Arch Biochem Biophys; 1996 Nov; 335(2):388-95. PubMed ID: 8914937
[TBL] [Abstract][Full Text] [Related]
12. Appearance of apparently ubiquitin-conjugated I kappa B-alpha during its phosphorylation-induced degradation in intact cells.
Traenckner EB; Baeuerle PA
J Cell Sci Suppl; 1995; 19():79-84. PubMed ID: 8655651
[TBL] [Abstract][Full Text] [Related]
13. Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo.
Roff M; Thompson J; Rodriguez MS; Jacque JM; Baleux F; Arenzana-Seisdedos F; Hay RT
J Biol Chem; 1996 Mar; 271(13):7844-50. PubMed ID: 8631829
[TBL] [Abstract][Full Text] [Related]
14. Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required.
Van Antwerp DJ; Verma IM
Mol Cell Biol; 1996 Nov; 16(11):6037-45. PubMed ID: 8887633
[TBL] [Abstract][Full Text] [Related]
15. Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-kappaB control.
Marienfeld R; Berberich-Siebelt F; Berberich I; Denk A; Serfling E; Neumann M
Oncogene; 2001 Dec; 20(56):8142-7. PubMed ID: 11781828
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of NF-kappa B inhibitor I kappa B alpha: ubiquitin-dependent proteolysis and its degradation product.
Li CC; Dai RM; Longo DL
Biochem Biophys Res Commun; 1995 Oct; 215(1):292-301. PubMed ID: 7575604
[TBL] [Abstract][Full Text] [Related]
17. A novel in vitro assay for deubiquitination of I kappa B alpha.
Strayhorn WD; Wadzinski BE
Arch Biochem Biophys; 2002 Apr; 400(1):76-84. PubMed ID: 11913973
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide.
Gao Y; Lecker S; Post MJ; Hietaranta AJ; Li J; Volk R; Li M; Sato K; Saluja AK; Steer ML; Goldberg AL; Simons M
J Clin Invest; 2000 Aug; 106(3):439-48. PubMed ID: 10930447
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132.
Fiedler MA; Wernke-Dollries K; Stark JM
Am J Respir Cell Mol Biol; 1998 Aug; 19(2):259-68. PubMed ID: 9698598
[TBL] [Abstract][Full Text] [Related]
20. Activation of NF-kappa B/Rel by Tax involves degradation of I kappa B alpha and is blocked by a proteasome inhibitor.
Maggirwar SB; Harhaj E; Sun SC
Oncogene; 1995 Sep; 11(5):993-8. PubMed ID: 7675460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
